Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP1061923B1 Metal chelators for use in the treatment of alzheimer's disease
06/15/2005EP1032380A4 Use of delta 5-androstene-3 beta-ol-7,17-dione in the treatment of lupus erythematosus
06/15/2005EP1010699B1 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
06/15/2005EP1007068B1 Process for preparing synthetic soil-extract materials and medicaments based thereon
06/15/2005EP0996732B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/15/2005EP0994704B1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005EP0979099B1 Use of lactoferin in the treatment of allergen induced disorders
06/15/2005EP0977564B1 Forskolin for promoting lean body mass
06/15/2005EP0975608B1 Halo-alkoxycarbonyl prodrugs
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005EP0967985B1 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
06/15/2005EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones
06/15/2005EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/15/2005EP0906108B1 Endothelin antagonists for treating heart failure
06/15/2005EP0805677B1 Extended release clonidine formulation
06/15/2005EP0730462B1 Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity
06/15/2005CN1628179A Gene and protein relating to hepatocellular carcinoma
06/15/2005CN1628119A Derivatives of 2,2,4-trisubstiotuted tetrahydrofuran as anti fungal agents
06/15/2005CN1628117A Biocidal compounds and their preparation
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628115A 哌啶衍生物 Piperidine derivatives
06/15/2005CN1628113A Substituted indoles as alpha-1 agonists
06/15/2005CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic
06/15/2005CN1628111A 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
06/15/2005CN1628106A Salts of valsartan
06/15/2005CN1628104A Quinazolinone derivatives and their use as CB agonists
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628102A Pyridineamido derivatives as inhibitors of monoamine oxidase (MAO-B)
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1628099A Water soluble phenylglycine derivatives
06/15/2005CN1628088A Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
06/15/2005CN1627970A Safety shield system for prefilled syringe
06/15/2005CN1627961A Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues
06/15/2005CN1627959A Pharmaceutical compositions for hepatitis C viral protease inhibitors
06/15/2005CN1627957A Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
06/15/2005CN1627954A Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn
06/15/2005CN1627951A Compositions and method for prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
06/15/2005CN1627950A Stable pharmaceutical composition useful for treating gastrointestinal disorders
06/15/2005CN1627949A Cycloglycans suitable to inhibit mammalian infection
06/15/2005CN1627948A Compsn. and its for treatment of inflammatory bowel diseases
06/15/2005CN1627947A Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
06/15/2005CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers
06/15/2005CN1627945A Quinoline derivatives as NPY antagonists
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1627943A New usage of dl-THP
06/15/2005CN1627942A Process for isolating srtemisinin from artemisia annua
06/15/2005CN1627941A Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
06/15/2005CN1627940A Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
06/15/2005CN1627939A Bicyclic CB2 cannabinoid receptor ligands
06/15/2005CN1627938A Pharmaceutical dosage form for mucosal delivery
06/15/2005CN1627937A Oral pediatric trimethobenzamide formulations and methods
06/15/2005CN1627935A Oral trimethobenzamide formulations and methods
06/15/2005CN1627924A Medical device with coating that promotes endothelial cell adherence and differentiation
06/15/2005CN1627900A Formulations comprising triazoles and alkoxylated amines
06/15/2005CN1626679A Methods for assessing and treating cancer
06/15/2005CN1626566A Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
06/15/2005CN1626546A New method for preparing Ciclesonide medication for treating asthma disease
06/15/2005CN1626545A Compound extracted from hull and stem of yellow horn, extracting method and application
06/15/2005CN1626543A Beta-2'-deoxygenation-ramification of nucleotide, synthetic method and application of medication
06/15/2005CN1626538A Phosphorylated glyceryl ether aluminium salts
06/15/2005CN1626536A Method of purifying moxidectin through crystallization
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1626533A Process for preparation of sulfonamide derivs. and crystals thereof
06/15/2005CN1626532A Amide compounds
06/15/2005CN1626530A Spiro and dispiro -1,2,4-trioxalane antimalarials
06/15/2005CN1626521A Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1626507A Compound of antitumor antibiotic of new carbon framework as well as preparation method and application
06/15/2005CN1626244A Combination for treating skin disease
06/15/2005CN1626240A Antigen-specific lgE antibody production inhibitors
06/15/2005CN1626238A Composition of multiple scattered mixture contg.polypeptide and its pharm compsn.
06/15/2005CN1626109A Substance of poly pentenol capsule and its prepn. method
06/15/2005CN1626108A Acarbose enteric coated tablets and its prepn. method
06/15/2005CN1626107A Pyrimidine nucleoside and pharmacy usage of pyrimidine nucleotide precursor
06/15/2005CN1626106A Medication for preventing and treating diseases of pigs
06/15/2005CN1626105A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626104A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626103A Combination of medication of containing general saponin of notoginseng and icariin as well as usage
06/15/2005CN1626102A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626101A Nano emulsion of containing ginsenoside, preparation method and usage
06/15/2005CN1626100A Injection of liposome of daunorubicin or hydrochloric daunorubicin and preparationmethod
06/15/2005CN1626099A Extractive of 'Zong'wood for treating diabetes, and application of saponin of 'Zong' wood for treating diabetes
06/15/2005CN1626098A Clindamycin hydrochloride oral desintegration tablet and prepartion method
06/15/2005CN1626097A Cyclovirobuxine D oral desintegration tablet and prepartion method
06/15/2005CN1626096A Huangyangning drop pills and preparation method
06/15/2005CN1626095A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
06/15/2005CN1626094A Quetiapingranulater
06/15/2005CN1626093A Oxacarbazepine film-coated tablets
06/15/2005CN1626092A Cefaclor oral desintegration tablet and preparation method Cefaclor
06/15/2005CN1626091A Combination of medicine for colds in use for treating non-phlegmatic cough and preparation method
06/15/2005CN1626090A Combination of medication for antivirus in use for eye region and preparation method
06/15/2005CN1626089A Valaciclovir oral desintegration tablet and preparation method
06/15/2005CN1626088A Hydrolase inhibitor of adenosine homeotypic cysteamine acid and usage
06/15/2005CN1626087A New usage of STI-571 in application for treating acute leukaemia in marrow type
1 ... 4655 4656 4657 4658 4659 4660 4661 4662 4663 4664 4665 4666 4667 4668 4669 4670 4671 4672 4673 4674 4675 ... 7860